What is Zimmer Biomet Holdings's market cap?

Zimmer Biomet Holdings (ZBH) has a market capitalization of $16.9B and trades on NYSE.

What is Zimmer Biomet Holdings's revenue and profitability?

Zimmer Biomet Holdings generated $8.4B in trailing twelve-month revenue with net income of $761.1M, representing a net margin of 9.1%. Gross margin stands at 70.0%, with free cash flow of $1.5B. These figures are based on the Q1 2026 filing.

Who are Zimmer Biomet Holdings's competitors?

Zimmer Biomet Holdings's key competitors include Stryker Corporation, Johnson & Johnson MedTech, Enovis, and others. These companies compete in similar markets and product categories.

Who does Zimmer Biomet Holdings partner with?

Zimmer Biomet Holdings's notable partners include Seikagaku Corporation, Apple.

What subsidiaries does Zimmer Biomet Holdings have?

Zimmer Biomet Holdings's subsidiaries include Biomet, Inc., LVB Acquisition, Inc..

Where is Zimmer Biomet Holdings headquartered?

Zimmer Biomet Holdings is headquartered in United States of America and employs approximately 18,000 people. It has been publicly traded since 2001.

Zimmer Biomet Holdings

ZBH

Zimmer Biomet is a global medical technology leader specializing in musculoskeletal healthcare.

Market cap

$16.94B-8.6%

Revenue$8.4B+9.2%

Net income$761.1M-16.7%

Free cash flow$1.5B-0.2%

EPS (diluted)$3.86-14.4%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

April 28, 2026

Revenue$2.1BBeat by $16.2M EPS$2.09Beat by $0.23

Read the full report

Next report

Aug 6, 2026 (In 3 weeks)

Revenue estimate$2.1B

EPS estimate$2.01

Financials

Q1 2026

Income statement

See full

Revenue$2.1B+9.3%

Gross profit$1.5B+11.1%

Operating income$373.2M+27.7%

Net income$238.1M+30.8%

EPS (diluted)$1.22+34.1%

Balance sheet

See full

Cash & equivalents$424.2M-69.4%

Total debt$7.5B+4.1%

Total equity$12.7B+2.2%

Total assets$22.7B+2.4%

Cash flow

See full

Operating cash flow$359.4M-6.1%

CapEx$36.3M-18.6%

Free cash flow$323.1M-4.5%

Valuation & ratios

Valuation

See full

Market cap$16.94B-8.6%

Enterprise value$23.99B-6.1%

P/E22.3×-0.3×

P/S2×-0.4×

Profitability

See full

Gross margin70%-1.0pp

Operating margin14%-3.0pp

Net margin9.1%-2.8pp

FCF margin17.3%-1.6pp

Returns & leverage

See full

Return on equity6.1%-1.2pp

Debt / equity0.6×0.0×

Current ratio1.7×-0.7×

Segments

By product

See full

Knees$828.6M+4.5%

SET$562.2M+19.5%

Hips$524.1M+5.7%

Technology And Data Bone Cement And Surgical$171.8M+14.6%

By geography

See full

Americas$1.3B+9.7%

EMEA$489.9M+10.9%

Asia Pacific$272.3M+4.5%

Competitors

By market cap

Johnson & Johnson$634.06B+68.9%

Stryker$125.30B-17.1%

Medtronic$104.98B-7.3%

Zimmer Biomet Holdings$16.9B-8.6%

Globus Medical$10.3B+29.1%

Enovis$1.4B-29.2%

Orthofix Medical Inc.$466.5M+7.1%

Xtant Medical Holdings$54.7M-43.2%

By revenue growth

Globus Medical+23.5%

Zimmer Biomet Holdings+9.2%

Stryker+8.8%

Medtronic+8.4%

Johnson & Johnson+7.9%

Enovis+6.0%

Orthofix Medical Inc.+2.6%

Xtant Medical Holdings-0.3%

By net margin

Johnson & Johnson21.83%-2.6pp

Globus Medical18.92%+11.5pp

Stryker13.21%+0.9pp

Medtronic13.2%-0.7pp

Zimmer Biomet Holdings9.05%-2.8pp

Xtant Medical Holdings1.5%+11.3pp

Orthofix Medical Inc.-7.27%+10.5pp

Enovis-49.91%-12.3pp

Profile

Zimmer Biomet is a global medical technology leader specializing in musculoskeletal healthcare. The company designs, manufactures, and markets orthopedic reconstructive products, robotic surgical systems, and digital health solutions aimed at improving patient mobility and health outcomes. Its core value proposition centers on a comprehensive portfolio that integrates traditional implants with advanced data analytics and artificial intelligence.

Competitive position

A global leader in the musculoskeletal market with a dominant position in knee and hip reconstruction and an increasing focus on robotic-assisted surgery.

GeographiesUnited States, Europe, Middle East, Africa, Asia Pacific

Customer segmentsHospitals, Ambulatory Surgery Centers, Specialist Physicians, Group Purchasing Organizations

Business modelManufacturing, Direct Sales, Consignment, Distributor-based sales

SuppliersRaw material suppliers, Specialized component manufacturers, Technology licensing partners, Third-party logistics providers

CustomersHospitals, Ambulatory surgery centers, Orthopedic surgeons, Stocking distributors, Healthcare dealers

CountryUnited States of America

Listed2001

Employees18.0K

CEOIvan Tornos

SectorHealthcare

IndustryMedical - Devices

Websitezimmerbiomet.com

FilingsSEC EDGAR

Ask your AI about Zimmer Biomet Holdings.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zimmer Biomet Holdings's market cap?: Zimmer Biomet Holdings (ZBH) has a market capitalization of $16.9B and trades on NYSE.
What is Zimmer Biomet Holdings's revenue and profitability?: Zimmer Biomet Holdings generated $8.4B in trailing twelve-month revenue with net income of $761.1M, representing a net margin of 9.1%. Gross margin stands at 70.0%, with free cash flow of $1.5B. These figures are based on the Q1 2026 filing.
Who are Zimmer Biomet Holdings's competitors?: Zimmer Biomet Holdings's key competitors include Stryker Corporation, Johnson & Johnson MedTech, Enovis, and others. These companies compete in similar markets and product categories.
Who does Zimmer Biomet Holdings partner with?: Zimmer Biomet Holdings's notable partners include Seikagaku Corporation, Apple.
What subsidiaries does Zimmer Biomet Holdings have?: Zimmer Biomet Holdings's subsidiaries include Biomet, Inc., LVB Acquisition, Inc..
Where is Zimmer Biomet Holdings headquartered?: Zimmer Biomet Holdings is headquartered in United States of America and employs approximately 18,000 people. It has been publicly traded since 2001.